Sponsored by: GE Healthcare

Molecular Imaging

LLMs rapidly evolving in nuclear medicine
By Will Morton
Large language models (LLMs) are widely used to handle the large volume of text data generated in nuclear medicine.
October 27, 2025
Artificial Intelligence Ai Hand 400
PET/MRI begins to deliver in breast cancer
By Philip Ward
The clinical role of PET/MRI is evolving rapidly in breast cancer, according to two studies presented at the European Society of Breast Imaging annual meeting.
October 23, 2025
Dedicated breast F-18 FDG PET/MRI exam pre- (A, D, G), mid- (B, E, H), and post-NAC (C, F, I) of a 41-year-old patient diagnosed with a triple negative (TN), grade 2, invasive carcinoma. The SUVmax values of the primary tumor were 14.68 pre-NAC, 1.69 mid-NAC, and 1.87 post-NAC, while SER values were 1.19, 0.52, and 0.63, respectively. Figure courtesy of Melissa Lenaerts, PhD, Dr. Thiemo van Nijnatten, PhD, et al and presented at EUSOBI 2025.
EUSOBI: Positron emission mammography demonstrates worth
By Edna Astbury-Ward, PhD
Positron emission mammography is proving useful in the presurgical assessment of invasive lobular carcinoma, researchers reported at the European Society of Breast Imaging (EUSOBI) annual meeting.
October 22, 2025
A 399 Fig 2 Pem Vs Cesm E Poster Eusobi 2025 Deabes Thumbnail
Amyloid PET can track patterns of neurodegeneration
By Maryam Payne
Early perfusion amyloid-PET shows potential for diagnosing and monitoring neurodegenerative disease and has possible advantages over FDG-PET scanning.
October 22, 2025
2025 10 20 Eanm Early Perfusion Imaging Fig1 Thumbnail
PSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancer
By Will Morton
Replacing F-18 sodium fluoride (NaF) PET/CT with F-18 PSMA PET/CT can improve treatment for men with newly diagnosed prostate cancer.
October 13, 2025
2025 10 09 Jnumed Psma Pet Vs Na F Pet Thumbnail
Will AI lead to merger of radiology and pathology?
By Edna Astbury-Ward, PhD
A strategic merger of radiology and pathology into a unified specialty is vital, two experts have warned in an 8 October commentary in European Journal of Radiology AI.
October 9, 2025
Glowing Neon Skeleton Nervous System Adobe Yuliia
GLP-1 drugs may confound PET/CT imaging findings
By AuntMinnieEurope.com staff writers
GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, according to research presented at the annual meeting of the European Association of Nuclear Medicine.
October 8, 2025
Semaglutide Injection Pen
GEHC, Erasmus MC to collaborate on PET/CT
By AuntMinnieEurope.com staff writers
GE HealthCare (GEHC) and Erasmus MC in Rotterdam, the Netherlands, are collaborating on evaluating next-generation total body PET/CT technology.
October 7, 2025
Erasmus Mc Resized
PET/CT links metabolic activity to aggressive endometrial cancer
By AuntMinnieEurope.com staff writers
Aggressive endometrial cancer may drive the high metabolic activity of visceral fat, Norwegian researchers reported in Barcelona at the 40th anniversary meeting of the European Association of Nuclear Medicine.
October 5, 2025
Eanm 2025 Congress Poster
French AI startup adds PSMA model to PET/CT AI assistant
By AuntMinnieEurope.com staff writers
Nuclear medicine AI start-up Paire has added a prostate-specific membrane antigen (PSMA) model to its PET/CT AI assistant, Pionus.
October 2, 2025
Ai 1
Serac highlights initial results of SPECT agent
By AuntMinnieEurope.com staff writers
Serac Healthcare and the University of Exeter, U.K., are highlighting findings for an imaging marker in evaluating lung disease.
September 29, 2025
Lung Technology Medicine 400
Growth opportunities mount for molecular imaging
By Sarah-Jane James
The molecular imaging market is entering an exciting phase. Challenges such as isotope fragility, stretched replacement cycles, and reimbursement complexities are outweighed by structural growth factors.
September 29, 2025
Neuroimaging Brain Pet Scan
Page 1 of 123
Next Page